Literature DB >> 11892249

Lentiviral vectors for the gene therapy of lympho-hematological disorders.

P Salmon1, D Trono.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11892249     DOI： 10.1007/978-3-642-56114-6_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  3 in total

Review 1.  Gene therapy of chronic granulomatous disease: the engraftment dilemma.

Authors:  Manuel Grez; Janine Reichenbach; Joachim Schwäble; Reinhard Seger; Mary C Dinauer; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

2.  rna interference targeting p110β reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo.

Authors:  Jian-bin Huang; Yue Ding; Dong-sheng Huang; Wei-ke Zeng; Zhi-ping Guan; Mao-lin Zhang
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

3.  PI3P signaling regulates receptor sorting but not transport in the endosomal pathway.

Authors:  A Petiot; J Faure; H Stenmark; J Gruenberg
Journal:  J Cell Biol       Date:  2003-09-15       Impact factor: 10.539
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.